Medicus Financial Statements From 2010 to 2026

MDCX Stock  USD 1.21  0.02  1.63%   
Medicus Pharma's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Medicus Pharma's valuation are provided below:
Market Capitalization
34.3 M
Earnings Share
(2.23)
We have found ninety-two available fundamental ratios for Medicus Pharma, which can be analyzed and compared to other ratios and to its peers in the industry. All investors should make sure to check all of Medicus Pharma last-minute market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 11.8 M in 2026. Enterprise Value is likely to drop to about 15.2 M in 2026
Check Medicus Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medicus Pharma's main balance sheet or income statement drivers, such as Interest Expense of 1.1 M, Selling General Administrative of 9.2 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 7.05. Medicus financial statements analysis is a perfect complement when working with Medicus Pharma Valuation or Volatility modules.
  
Build AI portfolio with Medicus OTC BB Equity
Check out the analysis of Medicus Pharma Correlation against competitors.

Medicus Pharma Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets6.8 M6.5 M1.5 M
Slightly volatile
Total Current Liabilities4.2 M2.7 M4.1 M
Slightly volatile
Accounts Payable1.2 M1.2 M449.2 K
Pretty Stable
CashM4.8 M974.8 K
Slightly volatile
Other Assets2.7 KK3.3 K
Slightly volatile
Long Term Debt515.3 K579.8 K632.8 K
Slightly volatile
Net Receivables1.5 M1.7 M1.8 M
Slightly volatile
Inventory847.9 K953.9 KM
Slightly volatile
Other Current Assets37 K41.6 K45.4 K
Slightly volatile
Total Liabilities4.3 M2.9 M4.1 M
Slightly volatile
Short and Long Term Debt1.8 M1.8 M777.3 K
Slightly volatile
Total Current Assets6.5 M6.2 M1.4 M
Slightly volatile
Short Term Debt3.3 K3.5 K100.4 K
Slightly volatile
Common Stock107.2 K102.1 K61.8 K
Slightly volatile
Property Plant Equipment20.6 K23.2 K25.3 K
Slightly volatile
Other Liabilities80 K90 K98.2 K
Slightly volatile
Other Current Liabilities11.3 M12.5 M10.2 M
Slightly volatile
Net DebtM1.5 M784.5 K
Slightly volatile
Common Stock Shares Outstanding9.9 M13.6 M8.7 M
Slightly volatile
Capital Stock36.9 M35.1 M7.3 M
Slightly volatile

Medicus Pharma Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative9.2 M8.8 M1.9 M
Slightly volatile
Research Development4.3 M4.1 M1.6 M
Slightly volatile
Interest Income83.5 K94 K102.6 K
Slightly volatile

Medicus Pharma Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings6.2 M5.9 M1.4 M
Slightly volatile
Depreciation244274300
Slightly volatile
Change To Operating Activities384.5 K432.5 K472.1 K
Slightly volatile
Total Cash From Financing Activities15.3 M14.6 M3.2 M
Slightly volatile
Sale Purchase Of Stock8.3 K9.4 K10.2 K
Slightly volatile
End Period Cash FlowM4.8 M1.3 M
Slightly volatile
Begin Period Cash Flow2.1 MM814.6 K
Slightly volatile
Other Non Cash Items138.7 K146 K536 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Cash Per Share0.220.390.1055
Slightly volatile
Income Quality0.610.830.7188
Pretty Stable
Current Ratio2.22.10.5392
Slightly volatile
Interest Debt Per Share0.07270.07650.1542
Pretty Stable
Debt To Assets0.06230.06566.338
Slightly volatile
Ebt Per Ebit1.451.151.386
Slightly volatile
Quick Ratio2.22.10.5392
Slightly volatile
Cash Ratio1.711.630.4386
Slightly volatile
Debt Ratio0.06230.06566.338
Slightly volatile

Medicus Pharma Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap11.8 M21 M19.2 M
Slightly volatile
Enterprise Value15.2 M22.5 M19.7 M
Slightly volatile

About Medicus Pharma Financial Statements

Medicus Pharma investors use historical fundamental indicators, such as Medicus Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Medicus Pharma. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Medicus OTC BB Equity Analysis

When running Medicus Pharma's price analysis, check to measure Medicus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicus Pharma is operating at the current time. Most of Medicus Pharma's value examination focuses on studying past and present price action to predict the probability of Medicus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicus Pharma's price. Additionally, you may evaluate how the addition of Medicus Pharma to your portfolios can decrease your overall portfolio volatility.